These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 24626869)
21. The control of pertussis--2007 and beyond. Halperin SA N Engl J Med; 2007 Jan; 356(2):110-3. PubMed ID: 17215528 [No Abstract] [Full Text] [Related]
22. Whooping cough in adults: an update on a reemerging infection. Paisley RD; Blaylock J; Hartzell JD Am J Med; 2012 Feb; 125(2):141-3. PubMed ID: 22269615 [TBL] [Abstract][Full Text] [Related]
23. Can we conquer coqueluche? Lynfield R; Schaffner W J Infect Dis; 2014 Apr; 209 Suppl 1():S1-3. PubMed ID: 24626865 [No Abstract] [Full Text] [Related]
25. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365 [TBL] [Abstract][Full Text] [Related]
30. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704 [TBL] [Abstract][Full Text] [Related]
31. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Witt MA; Arias L; Katz PH; Truong ET; Witt DJ Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373 [TBL] [Abstract][Full Text] [Related]
32. Acellular pertussis vaccine is licensed for infants. Marwick C JAMA; 1996 Aug; 276(7):516-8. PubMed ID: 8709389 [No Abstract] [Full Text] [Related]
34. The decline and resurgence of pertussis in the US. Rohani P; Drake JM Epidemics; 2011 Sep; 3(3-4):183-8. PubMed ID: 22094341 [TBL] [Abstract][Full Text] [Related]
35. Pertussis re-emergence in the post-vaccination era. Chiappini E; Stival A; Galli L; de Martino M BMC Infect Dis; 2013 Mar; 13():151. PubMed ID: 23530907 [TBL] [Abstract][Full Text] [Related]
36. An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines. Geier DA; Geier MR Brain Dev; 2004 Aug; 26(5):296-300. PubMed ID: 15165669 [TBL] [Abstract][Full Text] [Related]
37. New pertussis vaccination approaches: en route to protect newborns? Locht C; Mielcarek N FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832 [TBL] [Abstract][Full Text] [Related]
38. Re-emergence of diphtheria and pertussis: implications for Nigeria. Sadoh AE; Oladokun RE Vaccine; 2012 Nov; 30(50):7221-8. PubMed ID: 23102975 [TBL] [Abstract][Full Text] [Related]
39. Immunization update: pertussis, meningoccocus, and human papillomavirus. Middleman AB Adolesc Med Clin; 2006 Oct; 17(3):547-63; abstract ix-x. PubMed ID: 17030279 [TBL] [Abstract][Full Text] [Related]